This company has been marked as potentially delisted and may not be actively trading. Obesity ETF (SLIM) News Today Add Compare Share Share Headlines Stock AnalysisBuy This Stock SLIM Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 Time Period Viking Therapeutics Shares Nosedive Toward Worst Day Ever After Obesity Trial DataAugust 19, 2025 | forbes.comCIBC’s Investment Grade Bond ETFs Reach One-Year MarkJuly 25, 2025 | theglobeandmail.comTerns Pharmaceuticals: A Risky Buy Ahead Of Q4 Obesity, Oncology CatalystsJuly 11, 2025 | seekingalpha.comRhythm: Oral Bivamelagon Data Signals Dominance In Hypothalamic Obesity MarketJuly 10, 2025 | seekingalpha.comZealand Pharma Obesity Therapy Shows Positive Trial ResultsJune 18, 2025 | marketwatch.comBeyond Obesity: Eli Lilly's Genetic Medicine Bet On Verve TherapeuticsJune 18, 2025 | forbes.comFresenius Medical Care CEO Says Company Could Benefit From Obesity DrugsJune 17, 2025 | wsj.comEli Lilly: Obesity Drug Development To Go Beyond That Of ZepboundMay 16, 2025 | seekingalpha.comThe slim get slimmer, the heavy wait: Obesity drug divide growsApril 30, 2025 | msn.comRhythm: Late-Stage Study Win Brings About Change For Rare Obesity DisorderApril 8, 2025 | seekingalpha.com​Viking Therapeutics: Signs Of Insufficient Differentiation In Obesity Treatment​ (Rating Downgrade)March 10, 2025 | seekingalpha.comMissing protein keeps mice slim on high-fat dietFebruary 27, 2025 | msn.comMetsera: Capturing Of Obesity Market With Long-Acting GLP-1 DifferentiationFebruary 26, 2025 | seekingalpha.comScholar Rock: More Than Just An SMA Biotech With Q2 2025 Obesity Treatment DataJanuary 30, 2025 | seekingalpha.comViking Therapeutics: Investors Meeting Reality Of The Obesity MarketJanuary 23, 2025 | seekingalpha.comNovo Nordisk Vs. Eli Lilly: Obesity Makes Their Future Bright, But One Of Them Has More PotentialJanuary 6, 2025 | seekingalpha.comLilly's Obesity Drug Zepbound To Be Key Health Cost Driver For 2025January 1, 2025 | forbes.comEli Lilly's Obesity Drug Wins Approval In Sleep Apnea; Will ResMed Dive?December 20, 2024 | investors.comEli Lilly: Improved Competitive Position In Obesity Market, But Strong Execution Is A Must NowDecember 20, 2024 | seekingalpha.comNovo Nordisk Dives On CagriSegma Obesity Drug Trial. Eli Lilly, Viking Jump.December 20, 2024 | investors.comBillionaire Izzy Englander Is Buying This Obesity Drug Stock That Could Soar Nearly 20%, According to Wall StreetDecember 6, 2024 | fool.comViking Stock Pops, Then Drops On Latest Obesity / MASH Data - Why I'm Still BullishDecember 5, 2024 | seekingalpha.comVivani Medical to Present at the Innovation in Obesity Therapeutics Summit West CoastDecember 4, 2024 | businesswire.comAmgen slips as Cantor cites safety concerns linked to obesity candidateNovember 13, 2024 | seekingalpha.comCorbus Pharmaceuticals' Sell-Off: Speculative Entry Price In Oncology And Obesity TherapiesNovember 11, 2024 | seekingalpha.comAstraZeneca says experimental obesity pill ‘competitive,’ Bloomberg reportsNovember 5, 2024 | markets.businessinsider.comViking Therapeutics obesity data exceeded expectations, says JPMorganNovember 4, 2024 | markets.businessinsider.comViking Therapeutics’ Promising Results for Obesity TreatmentNovember 4, 2024 | markets.businessinsider.comViking Therapeutics' Hot Stock Slips After Latest Obesity Drug Trial ResultsNovember 4, 2024 | investopedia.comEli Lilly’s Bad Quarter Doesn’t Change the Long-Term Math on Obesity BonanzaOctober 30, 2024 | wsj.comAre Obesity and Alzheimer’s Linked? KGI Professor Awarded Grant to Find OutOctober 16, 2024 | markets.businessinsider.comAmgen’s stock falls as analyst warns that hype around obesity drug is baked inOctober 14, 2024 | msn.comSnack Slump Hits Big Food. Blame Prices, Not Obesity Meds.October 11, 2024 | msn.comMedicare coverage of obesity drugs could raise federal spending by $35B through 2034 - CBOOctober 9, 2024 | msn.comCan Novo, Lilly take credit for U.S. obesity rate decline?October 7, 2024 | msn.comObesity Drug Developer BioAge Labs Targets up to $640 Million Valuation in Upsized US IPOSeptember 25, 2024 | money.usnews.comNovo Nordisk Shares Drop More Than 4% on Disappointing Obesity Pill DataSeptember 20, 2024 | money.usnews.comTwo Rivers Police Department confirms human remains found to be Elijah VueSeptember 15, 2024 | yahoo.comObesity rates are above 20% in every U.S. state, CDC finds. 4 key takeaways from its latest report.September 14, 2024 | msn.comTandem Diabetes Care, Inc. (TNDM): Should You Add This Diabetes Stock To Your Portfolio Now?August 16, 2024 | msn.comMcKesson Stock Slides as Obesity Drug Shortages Weigh on DemandAugust 8, 2024 | wsj.comEli Lilly Earnings Show We Haven’t Hit Peak Obesity YetAugust 8, 2024 | wsj.comObesity Etf The Share Price (SLIM.US)August 4, 2024 | lse.co.ukAstraZeneca Says It Has A 'Powerful' — And Differentiated — Approach To Obesity TreatmentJuly 26, 2024 | msn.comSumatra Slim Belly Tonic Reviews (SCAM Alert) Can Sumatra Blue Tonic Really Help You Lose Weight? Honest Feedback From Users!July 19, 2024 | msn.comThis overlooked obesity-drug stock has 80% upside, JPMorgan saysMay 21, 2024 | markets.businessinsider.com'Ozempic Ftw:' Elon Musk Touts Novo Nordisk's Blockbuster Drug As Solution To Childhood Obesity ProblemMay 6, 2024 | msn.comAmgen Could Become A Real Contender In The Obesity MarketMay 5, 2024 | seekingalpha.comAt least 25,000 people in the US are starting weight-loss drug Wegovy each week, drugmaker saysMay 2, 2024 | ca.finance.yahoo.comGoldman Scrutinizes Hits, Misses, And Growth Trajectory Concerns For Eli Lilly And Its Its Obesity and Diabetes DrugsApril 30, 2024 | markets.businessinsider.com Get Obesity ETF News Delivered to You Automatically Sign up to receive the latest news and ratings for SLIM and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. SLIM Media Mentions By Week SLIM Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. SLIM News Sentiment▼0.001.34▲Average News Sentiment SLIM News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. SLIM Articles This Week▼00▲SLIM Articles Average Week Get the Latest News and Ratings for SLIM and Related Stocks Enter your email address to receive the latest news and analysts' ratings for Obesity ETF and its competitors. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies BIB News PPH News IBB News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:SLIM) was last updated on 8/29/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredThis is my Christian duty“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredAlex’s “Next Magnificent Seven” stocksThe original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...The Oxford Club | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredOut of 18,347 Cryptocurrencies... This is the ONLY OneThe Single Most Undervalued DeFi Protocol You've Never Heard Of If there's one cryptocurrency you should b...Crypto 101 Media | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding The Obesity ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share Obesity ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access